HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ilinskaya, O. N. Articles by Makarov, A. A. Search for Related Content PubMed PubMed Citation Articles by Ilinskaya, O. N. Articles by Makarov, A. A. Social Bookmarking                   What's this?

FOR THE RECORD

Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic

¹ Department of Microbiology, Kazan State University, 420008 Kazan, Russia
² Rudolf-Buchheim-Institute of Pharmacology, Justus-Liebig-University of Giessen, 35392 Giessen, Germany
³ Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
⁴ Department of Biology, Grove City College, Grove City, Pennsylvania 16127, USA
⁵ Department of Medical Biochemistry and Genetics, Texas A&M University, College Station, Texas 77843, USA

Reprint requests to: C. Nick Pace, Department of Medical Biochemistry and Genetics, Texas A&M University, College Station, Texas 77843, USA; e-mail: nickpace{at}tamu.edu; fax: (979) 847-9481 or Alexander A. Makarov, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov str. 32, 119991 Moscow, Russia; e-mail: aamakarov{at}genome.eimb.relarn.ru; fax: 7095-135-1405.

(RECEIVED May 22, 2002; FINAL REVISION July 3, 2002; ACCEPTED July 3, 2002)

Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.0216702.

	Abstract

TOP Abstract Introduction Results Discussion Materials and methods References

 
Ribonuclease Sa (pI = 3.5) from Streptomyces aureofaciens and its 3K (D1K, D17K, E41K) (pI = 6.4) and 5K (3K + D25K, E74K) (pI = 10.2) mutants were tested for cytotoxicity. The 5K mutant was cytotoxic to normal and v-ras-transformed NIH3T3 mouse fibroblasts, but RNase Sa and 3K were not. The structure, stability, and activity of the three proteins are comparable, but the net charge at pH 7 increases from -7 for RNase Sa to -1 for 3K and to +3 for 5K. These results suggest that a net positive charge is a key determinant of ribonuclease cytotoxicity. The cytotoxic 5K mutant preferentially attacks v-ras-NIH3T3 fibroblasts, suggesting that mammalian cells expressing the ras-oncogene are potential targets for ribonuclease-based drugs.

Keywords: Ribonuclease Sa; net charge; charge reversal mutants; cytotoxicity; v-ras-transformed fibroblasts

	Introduction

TOP Abstract Introduction Results Discussion Materials and methods References

 
The mammalian ribonucleases (RNases), of which RNase A is the best known, are the most rapidly evolving protein family. Some ribonucleases are cytotoxic, and they are being tested in clinical trials for use in cancer therapy (Leland and Raines 2001). Ribonucleases must enter the target cell and degrade the RNA to exert their cytotoxic effect (Wu et al. 1995). However, the molecular determinants of RNase-induced cell death are not well understood (Iordanov et al. 2000a). At least four members of the RNase A superfamily are endowed with antitumor activity and show cytotoxicity toward several tumor cell lines: BS-RNase from bull semen, onconase from oocytes of Rana pipiens, and two closely related sialic acid-binding lectins from oocytes of Rana catesbeiana and Rana japonica (Notomista et al. 2000). Ribonuclease activity is essential for cytotoxicity (Kim et al. 1995a,b). Members of the RNase A superfamily that are inhibited by ribonuclease inhibitor (RI) are not cytotoxic (Bretscher et al. 2000). For this reason, RNase A is not cytotoxic to cells containing RI. To circumvent this problem, site-directed mutagenesis is being used to alter the properties of RNase A so that it is not inhibited by RI (Bretscher et al. 2000).

The microbial RNases are another important family of RNases, and they are not inhibited by the RI from mammalian cells. A hybrid protein composed of Bacillus amyloliquefaciens ribonuclease (barnase) and Pseudomonas exotoxin A was toxic to different cell lines due to its ribonuclease activity (Prior et al. 1996). The ribonuclease from Bacillus intermedius (binase) exhibits antiproliferative action toward chicken embryo fibroblasts and mouse fibroblasts (Ilinskaya et al. 2001), and demonstrates genotoxic effects by induction of forward Ara^R-mutations and by histidine-reverse mutations as well as by prophage-induction activity (Ilinskaya et al. 1995). These results suggest that microbial ribonucleases might be useful agents for chemotherapy.

The smallest microbial ribonuclease is RNase Sa, a ribonuclease from Streptomyces aureofaciens. Wild-type RNase Sa is an acidic protein (pI = 3.5) that contains no Lys residues and has a net charge of -7 at pH 7 (Hebert et al. 1997). Replacement of Asp and Glu residues on the surface of RNase Sa with Lys residues was used to produce mutant RNases: 3K (D1K, D17K, E41K) with a net charge of -1 at pH 7, and 5K (3K + D25K, E74K) with a net charge of +3 at pH 7 (Shaw et al. 2001). These charge reversal mutants were stable and retained most of their enzyme activity (Shaw et al. 2001). These results and NMR studies (D. Laurents, unpubl.) suggested that the conformations of RNase Sa, 3K, and 5K are very similar. Futami et al. (2001) used chemical modification to increase the positive charge on bovine RNase A and human RNase 1. They found that this procedure made the enzymes less sensitive to inhibition by RI, and better able to enter cells. Finding that an extracellular human enzyme such as RNase 1 could be effectively internalized into cells by increasing the net positive charge suggested a simple strategy for improving the efficient delivery of other cytotoxic ribonucleases into cells (Futami et al. 2001).

In this paper, we report studies of the cytotoxicity of RNase Sa and its 3K and 5K mutants. We provide further evidence that the net charge of the molecule is an important determinant of ribonuclease cytotoxicity. The selectivity of toxic action to normal and tumor cells is another important parameter. For example, v-ras-transformed NIH3T3 cells were more sensitive to onconase than the parental NIH3T3 fibroblasts (Smith et al. 1999), and binase demonstrated greater growth inhibition of v-ras-transformed cells than normal fibroblasts (Ilinskaya et al. 2001). We report similar selectivity in the cytotoxic effect of the 5K mutant of RNase Sa to normal NIH3T3 fibroblasts and fibroblasts expressing v-ras-oncogene.

	Results

TOP Abstract Introduction Results Discussion Materials and methods References

 
The 5K mutant of RNase Sa is a far more potent toxic agent toward fibroblast cell lines than RNase Sa or the 3K mutant (Fig. 1A, Table 1). At 50 µM concentration, this enzyme reduced cell viability to 24% for NIH3T3 and to 3% for v-ras-NIH3T3 fibroblasts, showing that the v-ras-transformed fibroblasts are more sensitive to the 5K mutant. The 3K mutant exhibited a weak toxic effect toward v-ras-transformed fibroblasts, and RNase Sa was nontoxic (Fig. 1A). A more detailed investigation by direct cell counting and a determination of respiration rate did not detect toxic effects for RNase Sa or the 3K mutant even after 48 h (data not shown).

View larger version (26K): [in this window] [in a new window]   Fig. 1. (A) Viability of normal NIH3T3 fibroblasts (blank columns) and v-ras-NIH3T3 fibroblasts (hatched columns) treated for 24 h with RNase Sa and its 3K and 5K mutants at a concentration of 500 µg/mL. Values are expressed as percent viability of control cells grown without RNase. (B,C) Effect of 5K RNase Sa on the cell number (B) and respiration rate (C) of normal NIH3T3 fibroblasts (blank columns) and v-ras-NIH3T3 fibroblasts (hatched columns) treated for 24 h with various concentrations of 5K RNase Sa: bars a and e, untreated; b and f, 10 µg/mL; c and g, 100 µg/mL; and d and h, 500 µg/mL.

	Discussion

TOP Abstract Introduction Results Discussion Materials and methods References

 
Unlike the mammalian ribonuclease family, microbial RNases are not inhibited by the ribonuclease inhibitor from human cells. Our goal was to use RNase Sa and its charge reversed mutants to gain a better understanding of ribonuclease cytotoxicity for the possible development of microbial ribonucleases as chemotherapeutics. We replaced Asp and Glu residues on the surface of RNase Sa with Lys residues to produce mutants with a strikingly different net charge. By reversing five charges on RNase Sa, we have changed it from one of the most acidic to one of the most basic proteins, and our results show clearly that this is sufficient to generate a cytotoxic ribonuclease.

Normal NIH3T3 fibroblasts were less sensitive to the 5K mutant of RNase Sa compared to v-ras-transformed fibroblasts. Similar data were obtained for binase (Ilinskaya et al. 2001) and onconase (Smith et al. 1999), suggesting the key role of a positive mediator (Ras) of the proliferative signal transduction for a cytotoxic response in fibroblasts.

It is known that ribonucleolytic activity is essential for the cytotoxicity of RNases (Kim et al. 1995a,b). Onconase, an anticancer ribonuclease, damages cellular tRNA and causes caspase-dependent apoptosis in targeted cells that depends on its RNase activity (Iordanov et al. 2000b). The SOS response-inducing potency as a marker of genotoxicity of native and mutant binases with altered catalytic properties strongly correlated with ribonucleolytic activity (Ilinskaya et al. 1996). An alkylated derivative of onconase with 2% residual ribonuclease activity was not toxic (Smith et al. 1999), and a mutant barnase with <2% residual catalytic activity and photooxidized binase were not nephrotoxic (Ilinskaya and Vamvakas 1997). Cationic variants of RNase A and RNase 1 created using chemical modification of their carboxyl groups exhibited no cytotoxic effect if their catalytic activity was less than 0.01% of the nonmodified enzyme (Futami et al. 2001). So, as expected, ribonucleases must retain a definite level of ribonucleolytic activity to be toxic to cells.

All three ribonucleases used in our work are active enzymes (Shaw et al. 2001). In comparison to wild-type RNase Sa, the value of k_cat/K_M for cleavage of poly(I) is reduced by 18% for 3K, and by 86% for 5K RNase Sa (Table 1). Cytotoxicity was only observed for 5K RNase Sa, which has the lowest catalytic activity of the ribonucleases tested. Similarly, mammalian ribonucleases made more positively charged by chemical modification and retaining only about 1.5% catalytic activity were cytotoxic toward Swiss mouse albino 3T3 cells transformed by SV40 (Futami et al. 2001). Thus, a definite level of catalytic activity is essential but not sufficient to generate cytotoxicity.

Klink and Raines (2000) demonstrated that the conformational stability of RNase A mutants correlates directly with the cytotoxicity. The melting temperatures of RNase Sa, 3K and 5K in Table 1 show that a feature other than stability determines the cytotoxicity of 5K.

Our results show that the cytotoxic properties of RNase Sa correlate with the change in net charge from negative to positive (Table 1). This probably allows the 5K mutant to bind tighter to the negatively charged glycolipids in the outer part of the plasma membrane than do RNase Sa and 3K. This then promotes entry of the enzyme into the cell and may be the rate-limiting step for cytotoxicity. This is in agreement with the results of Futami et al. (2001) that show that the cytotoxicity and cell binding ability of chemically modified bovine RNase A and human RNase 1 correlate with their net positive charge. Site-directed mutagenesis allows the creation of positively charged ribonucleases with enhanced toxicity and avoids the unfavorable side effects of chemical modification. Thus, the development of mutant ribonucleases with increased positive charge may lead to more effective therapeutics.

	Materials and methods

TOP Abstract Introduction Results Discussion Materials and methods References

 
Wild-type RNase Sa and the 3K and 5K mutants were prepared as described in Shaw et al. (2001). Two cell culture lines were used: normal NIH3T3 mouse fibroblasts and NIH3T3 mouse fibroblasts with retroviral stock from v-Ha-ras-transfected psi-2-cells. Ras encodes G (guanine-nucleotide-binding and GTP-hydrolyzing)-protein that is located on the inner face of the plasma membrane and couples growth factor receptors to effector proteins in the cell. The cellular G-protein (Ras) is involved in signal transmission and plays an important role in mitosis and differentiation, and its viral counterpart (v-Ras) is a constitutively active protein which leads to cellular transformation (Bishop 1991). Animal fibroblasts were maintained at 37°C in a humidified, 6% CO₂/94% air atmosphere in Dulbecco's modified Eagle's medium (pH 7.2) containing 5% calf serum, 2 mM L-glutamine, and antibiotics. After confluence, cultures were treated with trypsin for 1 min and cells were plated at a density of 6 x 10⁵ cells per 35-mm dish. Cells were cultivated for 24 h before addition of a ribonuclease. The ribonuclease concentration varied from 10 to 500 µg/mL.

Viability was assessed with the cell proliferation reagent WST-1 (Roche Diagnostics, Mannheim, Germany). This test is based on cleavage of a water-soluble tetrazolium salt by mitochondrial dehydrogenases in viable cells. Cells were incubated with WST-1 for 20 min. After centrifugation of liquid phase (at 5000g for 5 min), absorbance of aliquots of supernatants was measured at 450 nm. The cell-free medium/reagent mixture was used as the background control. Cell viability was calculated as the difference in absorbance between each variant and background according to Ilinskaya et al. (2001). The viability of untreated cells was taken as 100%. The cell number of each dish was counted after trypsinization in a cell chamber counter using a light microscope. Respiration rate was determined as a change in the absorbance of WST solution per h per 10⁶ cells. Values reported are the mean of three measurements with the standard deviation. Two groups of data were regarded as different if they satisfied the t-criterion with P<0.01.

	Acknowledgments

 
This work was supported in part by NIH FIRCA grant TW01058, DAAD (Deutscher Akademischer Austauschdienst), RFBR grant 02-04-48259, CRDF grant REC-007, grant "Universities of Russia UR 11.01.010", INTAS-RFBR grant 97-245, NIH grant GM 37039, Welch Foundation Grant BE-1060, and the Tom and Jean McMullin Professorship.

The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.

	References

TOP Abstract Introduction Results Discussion Materials and methods References

 
Bishop, J.M. 1991. Molecular themes in oncogenesis. Cell 64: 235–248.[CrossRef][Medline]

Bretscher, L.E., Abel, R.L., and Raines, R.T. 2000. A ribonuclease A variant with low catalytic activity but high cytotoxicity. J. Biol. Chem. 275: 9893–9896.[Abstract/Free Full Text]

Futami, J., Maeda, T., Kitazoe, M., Nukui, E,. Tada, H., Seno, M., Kosaka, M., and Yamada, H. 2001. Preparation of potent cytotoxic ribonuclease by cationization: Enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups. Biochemistry 40: 7518–7524.[Medline]

Hebert, E.J., Grimsley, G.R., Hartley, R.W., Horn, G., Schell, D., Garcia, S., Both, V., Sevcik, J., and Pace, C.N. 1997. Purification of ribonucleases Sa, Sa2, and Sa3 after expression in Escherichia coli. Protein Expr. Purif. 11: 162–168.

Ilinskaya, O.N. and Vamvakas, S. 1997. Nephrotoxic effects of bacterial ribonucleases in the isolated perfused rat kidney. Toxicology 120: 55–63.[CrossRef][Medline]

Ilinskaya, O.N., Ivanchenko, O.B., and Karamova, N.S. 1995. Bacterial ribonuclease: Mutagenic effect in microbial test-systems. Mutagenesis 10: 165–170.[Abstract/Free Full Text]

Ilinskaya, O.N., Karamova, N.S., Ivanchenko, O.B., and Kipenskaya, L.V. 1996. SOS-inducing ability of native and mutant microbial ribonucleases. Mutat. Res. 354: 203–209.[Medline]

Ilinskaya, O., Decker, K., Koschinski, A., Dreyer, F., and Repp, H. 2001. Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current. Toxicology 156: 101–107.[CrossRef][Medline]

Iordanov, M.S., Ryabinina, O.P., Wong, J., Dinh, T.H., Newton, D.L., Rybak, S.M., and Magun, B.E. 2000a. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Cancer Res. 60: 1983–1994.[Abstract/Free Full Text]

Iordanov, M.S., Wong, J., Newton, D.L., Rybak, S.M., Bright, R.K., Flavell, R.A., Davis, R.J., and Magun, B.E. 2000b. Differential requirement for the stress-activated protein kinase/c-Jun NH(2)-terminal kinase in RNAdamage-induced apoptosis in primary and in immortalized fibroblasts. Mol. Cell. Biol. Res. Commun. 4: 122–128.[CrossRef][Medline]

Kim, J.S., Soucek, J., Matousek, J., and Raines, R.T. 1995a. Mechanism of ribonuclease cytotoxicity. J. Biol. Chem. 270: 31097–31102.[Abstract/Free Full Text]

Kim, J.S., Soucek, J., Matousek, J., and Raines, R.T. 1995b. Catalytic activity of bovine seminal ribonuclease is essential for its immunosuppressive and other biological activities. Biochem. J. 308: 547–550.

Klink, T.A. and Raines, R.T. 2000. Conformational stability is a determinant of ribonuclease A cytotoxicity. J. Biol. Chem. 275: 17463–17467.[Abstract/Free Full Text]

Leland, P. and Raines, R. 2001. Cancer chemotherapy—Ribonucleases to the rescue. Chem. Biol. 8: 405–413.[CrossRef][Medline]

Notomista, E., Catanzano, F., Graziano, G., Dal Piaz, F., Barone, G., D'Alessio, G., and Di Donato, A. 2000. Onconase: An unusually stable protein. Biochemistry 39: 8711–8718.[CrossRef][Medline]

Prior, T.I., Kunwar, S., and Pastan, I. 1996. Studies on the activity of barnase toxins. Bioconjug. Chem. 7: 23–29.[CrossRef][Medline]

Shaw, K.L., Grimsley, G.R., Yakovlev, G.I., Makarov, A.A., and Pace, C.N. 2001. The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci. 10: 1206–1215.[Abstract/Free Full Text]

Smith, M.R., Newton, D.L., Mikulski, S.M., and Rybak, S.M. 1999. Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases. Exper. Cell Res. 247: 220–232.[CrossRef][Medline]

Wu, Y.N., Saxena, S.K., Ardelt, W., Gadina, M., Mikulski, S.M., De Lorenzo, V., D'Alessio, G., and Youle, R.J. 1995. A study of the intracellular routing of cytotoxic ribonucleases. J. Biol. Chem. 270: 17476–17481.[Abstract/Free Full Text]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Murata, J. Futami, M. Kitazoe, T. Yonehara, H. Nakanishi, M. Kosaka, H. Tada, M. Sakaguchi, Y. Yagi, M. Seno, et al. Intracellular Delivery of Glutathione S-transferase-fused Proteins into Mammalian Cells by Polyethylenimine-Glutathione Conjugates J. Biochem., October 1, 2008; 144(4): 447 - 455. [Abstract] [Full Text] [PDF]

				S. M. Fuchs, T. J. Rutkoski, V. M. Kung, R. T. Groeschl, and R. T. Raines Increasing the potency of a cytotoxin with an arginine graft Protein Eng. Des. Sel., October 22, 2007; (2007) gzm051v1. [Abstract] [Full Text] [PDF]

				A. J. Munoz-Gomez, M. Lemonnier, S. Santos-Sierra, A. Berzal-Herranz, and R. Diaz-Orejas RNase/Anti-RNase Activities of the Bacterial parD Toxin-Antitoxin System J. Bacteriol., May 1, 2005; 187(9): 3151 - 3157. [Abstract] [Full Text] [PDF]

				J. Matousek, G. Gotte, P. Pouckova, J. Soucek, T. Slavik, F. Vottariello, and M. Libonati Antitumor Activity and Other Biological Actions of Oligomers of Ribonuclease A J. Biol. Chem., June 20, 2003; 278(26): 23817 - 23822. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ilinskaya, O. N. Articles by Makarov, A. A. Search for Related Content PubMed PubMed Citation Articles by Ilinskaya, O. N. Articles by Makarov, A. A. Social Bookmarking                   What's this?